Skip to main content

CORRECTION article

Front. Mol. Biosci., 04 October 2024
Sec. Biological Modeling and Simulation
Volume 11 - 2024 | https://doi.org/10.3389/fmolb.2024.1490100

Corrigendum: Deepening insights into cholinergic agents for intraocular pressure reduction: systems genetics, molecular modeling, and in vivo perspectives

This article is a correction to:

  1. Deepening insights into cholinergic agents for intraocular pressure reduction: systems genetics, molecular modeling, and in vivo perspectives

    1. Read original article
Minjae J. KimMinjae J. Kim1Mohamed M. Ibrahim,Mohamed M. Ibrahim1,2Monica M. Jablonski, Monica M. Jablonski1,3*
  • 1Department of Ophthalmology, The Hamilton Eye Institute, The University of Tennessee Health Science Center, Memphis, TN, United States
  • 2Department of Pharmaceutics, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt
  • 3Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, United States

A Corrigendum on
Deepening insights into cholinergic agents for intraocular pressure reduction: systems genetics, molecular modeling, and in vivo perspectives

by Kim MJ, Ibrahim MM and Jablonski MM (2024). Front. Mol. Biosci. 11:1423351. doi: 10.3389/fmolb.2024.1423351

In the published article, there was an error in the Acknowledgments. The statement was incomplete and did not mention Robert Williams and Lu Lu. The correct Acknowledgements statement appears below.

“We extend our gratitude to Kirk Hevener and Wei Li for providing access to the molecular modeling station at the College of Pharmacy, University of Tennessee Health Science Center. We also extend our gratitude to Robert Williams and Lu Lu at the Department of Genetics, Genomics and Informatics, University of Tennessee Health Science Center. Funding was provided by a Challenge Grant from Research to Prevent Blindness to the Hamilton Eye Institute and R01EY021200 to MJ. Figures 1–4 were generated using BioRender.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: glaucoma, parasympathetic nervous system, systems genetics, virtual screening, molecular dynamics, quantitative structure-activity relationship, and in vivo efficacy

Citation: Kim MJ, Ibrahim MM and Jablonski MM (2024) Corrigendum: Deepening insights into cholinergic agents for intraocular pressure reduction: systems genetics, molecular modeling, and in vivo perspectives. Front. Mol. Biosci. 11:1490100. doi: 10.3389/fmolb.2024.1490100

Received: 02 September 2024; Accepted: 24 September 2024;
Published: 04 October 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Kim, Ibrahim and Jablonski. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Monica M. Jablonski, mjablonski@uthsc.edu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.